PMID: 11918250Mar 29, 2002Paper

Erectile dysfunction in a primary care setting: results of an observational, no-control-group, prospective study with sildenafil under routine conditions of use

International Journal of Impotence Research
A GilJ Rejas

Abstract

In order to assess the effectiveness of sildenafil under routine conditions of use in primary care settings and to evaluate its impact on patient's life satisfaction and partner's satisfaction with treatment for erectile dysfunction (ED), an open, multicentre, observational, prospective study was designed in which 2816 patients were treated with sildenafil for at least 10 weeks. Effectiveness was assessed using the International Index of Erectile Dysfunction (IIEF), life satisfaction was measured with 'Life-satisfaction Check List' (LISAT 8), and EDITS was optionally used to assess the partner's satisfaction with ED therapy. Sildenafil was effective in 86.6% of patients. All dimensions of IIEF significantly increased with sildenafil, particularly erectile domain which overall sample mean score improved was 13.2 points (P < 0.001). The greatest increases in satisfaction with all aspects of life were seen in sex life and relationship with partner dimensions. The patients' partners, answered by a minority of partners, were highly satisfied with the treatment and its rapid action, therefore they were in favour of continuing with same. The adverse events occurring were similar to those seen in clinical research on sildenafil in the ...Continue Reading

References

Dec 1, 1988·Archives of Sexual Behavior·B L Andersen, B Broffitt
May 1, 1995·British Journal of Urology·M JønlerR C Bruskewitz
Aug 1, 1996·British Journal of Urology·M BoolellM J Allen
Aug 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·T H WagnerP S Froese
Jun 1, 1997·The Journal of Urology·R J WillkeO I Linet
Oct 7, 1997·International Journal of Impotence Research·A R Fugl-MeyerK S Fugl-Meyer
Apr 2, 1998·BMJ : British Medical Journal·G H GuyattR S Goldstein
May 15, 1998·The New England Journal of Medicine·I GoldsteinP A Wicker
Nov 18, 1998·Psychotherapy and Psychosomatics·M FavaJ J Worthington
Apr 14, 1999·Cell Death and Differentiation·L NagyP J Davies
Jul 10, 1999·Drugs·H D Langtry, A Markham
Mar 4, 2000·Journal of Affective Disorders·S H KennedyR M Bagby

❮ Previous
Next ❯

Citations

Mar 10, 2007·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Ann-Christin JohanssonSteven J Linton
Nov 5, 2002·Urology·Harin Padma-nathanFrancesco Montorsi
Feb 9, 2007·International Journal of Impotence Research·C M KimUNKNOWN Korea Post-Marketing Surveillance Research Group
Dec 1, 2007·Clinical Interventions in Aging·Konstantinos Hatzimouratidis
Mar 21, 2007·The Journal of Sexual Medicine·Antonio Martin-MoralesAna Muñoz
Nov 29, 2007·The Journal of Sexual Medicine·Ignacio MoncadaJavier Rejas Gutiérrez
Oct 6, 2007·International Journal of Andrology·Massimo BocchioSandro Francavilla
Apr 10, 2004·Urology·Francesco Montorsi, Stanley E Althof
Mar 17, 2011·American Journal of Men's Health·John P MulhallMeeta Budhwani
Oct 29, 2004·International Journal of Impotence Research·S SunwooUNKNOWN Korea Post-Marketing Surveillance Research Group
Dec 13, 2003·International Journal of Impotence Research·B-P JiannJ-K Huang
Mar 2, 2011·Toxicology and Industrial Health·Mehdi RaissyEbrahim Rahimi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.